# Athersys Inc. (ATHX)

Source: https://www.quantisnow.com/company/ATHX
Generated: 2026-11-15T11:06:54.647Z

- Ticker: ATHX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: athersys.com

## About

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as in Phase II clinical study for the treatment of patients with acute myocardial infarction, and has completed Phase I clinical study for the treatment of patients suffering from leukemia or various other blood-borne cancers. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.

## Latest ATHX news and filings

- 2024-01-08 12:31 UTC [SEC Form 8-K] [Athersys Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/athersys-inc-filed-sec-form-8-k-entry-into-a-material-5174756)
- 2023-12-27 14:01 UTC [SEC Form 25-NSE filed by Athersys Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-athersys-inc-5155709)
- 2023-12-22 22:09 UTC [SEC Form 8-K] [Athersys Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update](https://www.quantisnow.com/insight/athersys-inc-filed-sec-form-8-k-costs-associated-with-exit-5153747)
- 2023-12-21 16:37 UTC [SEC Form 4] [Hansen Maia covered exercise/tax liability with 67 shares, decreasing direct ownership by 0.10% to 70,010 units (SEC Form 4)](https://www.quantisnow.com/insight/hansen-maia-covered-exercisetax-liability-with-67-shares-decreasing-direct-5150719)
- 2023-12-04 12:27 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Athersys Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-athersys-inc-5115159)
- 2023-11-30 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Athersys Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-athersys-inc-5109915)
- 2023-11-22 02:33 UTC [SEC Form S-1] [SEC Form S-1/A filed by Athersys Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-s-1a-filed-by-athersys-inc-amendment-5099890)
- 2023-11-16 13:36 UTC [Market Chatter] [Athersys Q3 EPS $(0.15)](https://www.quantisnow.com/insight/athersys-q3-eps-015-5089290)
- 2023-11-16 13:35 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Athersys Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-athersys-inc-5089289)
- 2023-11-16 13:30 UTC [Public Offering] [Athersys Reports Third Quarter 2023 Financial Results and Business Highlights](https://www.quantisnow.com/insight/athersys-reports-third-quarter-2023-financial-results-and-business-highlights-5089252)
- 2023-11-09 22:09 UTC [SEC Form S-1] [SEC Form S-1 filed by Athersys Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-athersys-inc-5076226)
- 2023-10-30 20:30 UTC [SEC Form 8-K] [Athersys Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/athersys-inc-filed-sec-form-8-k-entry-into-a-material-5044488)
- 2023-10-18 12:00 UTC [SEC Form 8-K] [Athersys Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events](https://www.quantisnow.com/insight/athersys-inc-filed-sec-form-8-k-notice-of-delisting-or-5025549)
- 2023-10-17 21:31 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-after-market-session-5024844)
- 2023-10-17 17:42 UTC [Market Insight] [Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session](https://www.quantisnow.com/insight/why-servisfirst-bancshares-shares-are-trading-lower-by-6-here-5024091)
- 2023-10-17 13:06 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-pre-market-session-5023368)
- 2023-10-17 12:12 UTC [Market Insight] [Why Vistagen Therapeutics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-vistagen-therapeutics-shares-are-trading-higher-by-around-13-5023116)
- 2023-10-16 20:55 UTC [Market Chatter] [Athersys Warrant Exercise Inducement Offer Letter To Raise Gross Proceeds Of Up To ~$3.9M From The Exercise Of 28,124,590 Warrants And Received The First Tranche Payment Of $1.5M From Healios K.K. Under The ARDS Global License](https://www.quantisnow.com/insight/athersys-warrant-exercise-inducement-offer-letter-to-raise-gross-proceeds-5022235)
- 2023-10-16 20:54 UTC [Market Chatter] [Athersys Extends Near Term Liquidity with Proceeds From Warrant Inducement And Global ARDS License With Healios To Explore Strategic Alternatives](https://www.quantisnow.com/insight/athersys-extends-near-term-liquidity-with-proceeds-from-warrant-inducement-5022225)
- 2023-10-16 20:52 UTC [Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives](https://www.quantisnow.com/insight/athersys-extends-near-term-liquidity-with-proceeds-from-warrant-inducement-5022218)
- 2023-10-12 13:28 UTC [SEC Form 8-K] [Athersys Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/athersys-inc-filed-sec-form-8-k-entry-into-a-material-5016884)
- 2023-10-11 17:13 UTC [Market Insight] [Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-astra-space-shares-are-trading-lower-by-22-here-5015122)
- 2023-10-11 13:27 UTC [SEC Form 8-K] [Athersys Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/athersys-inc-filed-sec-form-8-k-entry-into-a-material-5014688)
- 2023-10-11 13:06 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-pre-market-session-5014589)
- 2023-10-11 12:24 UTC [Market Insight] [Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-voxx-international-shares-are-trading-higher-by-around-12-5014404)
- 2023-10-10 21:32 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-after-market-session-5013631)
- 2023-10-10 18:46 UTC [Market Insight] [Crude Oil Moves Lower; Neogen Posts Downbeat Results](https://www.quantisnow.com/insight/crude-oil-moves-lower-neogen-posts-downbeat-results-5012749)
- 2023-10-10 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-intraday-session-5012669)
- 2023-10-10 17:08 UTC [Market Insight] [Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session](https://www.quantisnow.com/insight/why-startek-shares-are-trading-higher-by-29-here-are-5012637)
- 2023-10-10 16:04 UTC [Market Insight] [S&P 500 Rises 1%; US Wholesale Inventories Fall In August](https://www.quantisnow.com/insight/sp-500-rises-1-us-wholesale-inventories-fall-in-august-5012494)
- 2023-10-10 15:55 UTC [Market Insight] [Athersys shares are trading lower after the company said it intends to conduct additional data analysis with independent statisticians because the sample size in the Phase 3 MASTERS-2 is insufficiently powered to achieve the primary endpoint.](https://www.quantisnow.com/insight/athersys-shares-are-trading-lower-after-the-company-said-it-5012456)
- 2023-10-10 13:40 UTC [Market Insight] [US Stocks Gain; PepsiCo Posts Upbeat Earnings](https://www.quantisnow.com/insight/us-stocks-gain-pepsico-posts-upbeat-earnings-5012146)
- 2023-10-10 13:06 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-pre-market-session-5012002)
- 2023-10-10 12:51 UTC [Market Chatter] [Athersys, Inc. Shares To Resume Trade At 9:00 a.m. ET](https://www.quantisnow.com/insight/athersys-inc-shares-to-resume-trade-at-900-am-et-5011853)
- 2023-10-10 12:37 UTC [Market Chatter] [Athersys Reports Interim Analysis Results Of MASTERS-2 Clinical Study With MultiStem In Ischemic Stroke, Signs Memorandum Of Understanding For Global ARDS License With Healios; Includes $1.5M To $4.5M Near Term Payments Plus Up To $150M In Milestones](https://www.quantisnow.com/insight/athersys-reports-interim-analysis-results-of-masters-2-clinical-study-with-5011805)
- 2023-10-10 12:30 UTC [Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios](https://www.quantisnow.com/insight/athersys-reports-interim-analysis-results-of-masters-2-clinical-study-with-5011727)
- 2023-10-10 12:25 UTC [Market Chatter] [Athersys Shares Halted, News Pending](https://www.quantisnow.com/insight/athersys-shares-halted-news-pending-5011712)
- 2023-10-06 21:34 UTC [SEC Form 4] [Hansen Maia covered exercise/tax liability with 23,149 shares, decreasing direct ownership by 25% to 70,144 units (SEC Form 4)](https://www.quantisnow.com/insight/hansen-maia-covered-exercisetax-liability-with-23149-shares-decreasing-direct-5009813)
- 2023-10-06 21:28 UTC [SEC Form 4] [Camardo Daniel A. covered exercise/tax liability with 19,993 shares, decreasing direct ownership by 7% to 285,341 units (SEC Form 4)](https://www.quantisnow.com/insight/camardo-daniel-a-covered-exercisetax-liability-with-19993-shares-decreasing-5009799)
- 2023-10-03 20:41 UTC [SEC Form 8-K] [Athersys Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/athersys-inc-filed-sec-form-8-k-other-events-financial-statements-5001639)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ATHX
- Earnings history: https://www.quantisnow.com/earnings/ATHX
- Dividend history: https://www.quantisnow.com/dividends/ATHX
- Insider transactions: https://www.quantisnow.com/insiders/ATHX
- Options chain: https://www.quantisnow.com/options/ATHX
- SEC 8-K filings only: https://www.quantisnow.com/company/ATHX/8-k
- RSS and alerts for ATHX: https://www.quantisnow.com/docs/rss-feeds.md